Gamitrinib TPP hexafluorophosphate
Gamitrinib TPP hexafluorophosphate is a mitochondrially-targeted HSP90 inhibitor that disrupts cancer cell homeostasis and induces cell cycle arrest. Its application extends to research in oncology, neurodegenerative disorders, and virology, supported by evidence from both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1131626-47-5
Field of Research
Infectious Disease & Virology, Metabolism Research, Signal Transduction
Purity
98.52% (May vary between batches)
Smiles
O=C (C=C1NC (/C (C) =C\C=C\[C@@H] ([C@H] (/C (C) =C/[C@H] (C) [C@H] ([C@@H] (OC) C[C@@H] (C2) C) O) OC (N) =O) OC) =O) C (NCCCCCC[P+] (C3=CC=CC=C3) (C4=CC=CC=C4) C5=CC=CC=C5) =C2C1=O.F[P-] (F) (F) (F) (F) F
Molecular Formula
C52H65F6N3O8P2
Molecular Weight
1036.03
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog